Arbutus Biopharma (ABUS) PT Raised to $5 at JMP Securities
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $5.10 +0.20%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
JMP Securities analyst Roy Buchanan raised the price target on Arbutus Biopharma (NASDAQ: ABUS) to $5.00 (from $4.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Enovis Corp (ENOV) PT Lowered to $27 at BMO Capital
- MongoDB (MDB) PT Raised to $500 at Monness, Crespi, Hardt
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
